336 |
Hidayat R., Diafiri D., Zairinal R.A., Arifin G.R., Azzahroh F., Widjaya N., Fani D.N., Mesiano T., Kurniawan M., Rasyid A., Giantini A., Haris S. |
57225289998;57369144600;57214092762;57221703744;57219418635;57424739100;57424721100;57204830976;57196001182;56703146700;12776781400;57222343545; |
Acute Ischaemic Stroke Incidence after Coronavirus Vaccine in Indone-sia: Case Series |
2021 |
Current Neurovascular Research |
18 |
3 |
|
360 |
363 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85123387853&doi=10.2174%2f1567202618666210927095613&partnerID=40&md5=56196ab18737f980961c6a27a7823638 |
Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Universitas Indonesia Hospital, Universitas Indone-sia, Depok, Indonesia |
Hidayat, R., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Universitas Indonesia Hospital, Universitas Indone-sia, Depok, Indonesia; Diafiri, D., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Universitas Indonesia Hospital, Universitas Indone-sia, Depok, Indonesia; Zairinal, R.A., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Universitas Indonesia Hospital, Universitas Indone-sia, Depok, Indonesia; Arifin, G.R., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Azzahroh, F., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Widjaya, N., Universitas Indonesia Hospital, Universitas Indone-sia, Depok, Indonesia; Fani, D.N., Universitas Indonesia Hospital, Universitas Indone-sia, Depok, Indonesia; Mesiano, T., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Kurniawan, M., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Rasyid, A., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Giantini, A., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Universitas Indonesia Hospital, Universitas Indone-sia, Depok, Indonesia; Haris, S., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Background: Coronavirus disease-19 (COVID-19) is an infectious disease with high morbidity and mortality rates. Indonesia had reported a 2.8% of mortality rate up to June 2021. Case Presentation: A strategy to control the virus spreading is by vaccination. The Indonesian Food and Drug Monitoring Agency had approved the use of CoronaVac, an inactivated virus vaccine developed by Sinovac. Most Adverse Events Following Immunization (AEFI) for Corona-Vac are mild, and the most common symptoms are injection-site pain, headache, and fatigue. Neu-rovascular adverse events, including thrombosis or ischaemic stroke after receiving CoronaVac have not previously been reported. Conclusion: Correspondingly, we reported three patients with an Acute Ischaemic Stroke (AIS) after the administration of CoronaVac in our hospital. © 2021 Bentham Science Publishers. |
AEFI; CoronaVac; COVID 19; COVID-19; Stroke; Vaccine |
inactivated vaccine; adverse event; aged; brain ischemia; case report; human; incidence; Indonesia; male; middle aged; prevention and control; Aged; COVID-19; COVID-19 Vaccines; Humans; Incidence; Indonesia; Ischemic Stroke; Male; Middle Aged; SARS-CoV-2; Vaccines, Inactivated |
Bentham Science Publishers |
15672026 |
|
34579636 |
Article |
Q3 |
592 |
8538 |
|
|
491 |
Susanto A.D., Triyoga P.A., Isbaniah F., Fairuz A., Cendikiawan H., Zaron F., Aryanti I., Irbah S.N., Hidayat M. |
57190425587;57222896246;36489441300;57222895896;57222896833;57222896488;57222896415;57222896232;56435992700; |
Lung fibrosis sequelae after recovery from COVID-19 infection |
2021 |
Journal of Infection in Developing Countries |
15 |
3 |
|
360 |
365 |
|
3 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104167707&doi=10.3855%2fjidc.13686&partnerID=40&md5=622edaeb2b1f79f472a58df7a7dfdca2 |
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia-Persahabatan Hospital, Jakarta, Indonesia; Lung Clinic, Eka Hospital Cibubur, West Java, Indonesia; Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Radiology Departement, Eka Hospital Cibubur, West Java, Indonesia; Faculty of Medicine, University of Mataram, Mataram, West Nusa Tenggara, Indonesia |
Susanto, A.D., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia-Persahabatan Hospital, Jakarta, Indonesia, Lung Clinic, Eka Hospital Cibubur, West Java, Indonesia; Triyoga, P.A., Lung Clinic, Eka Hospital Cibubur, West Java, Indonesia; Isbaniah, F., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia-Persahabatan Hospital, Jakarta, Indonesia; Fairuz, A., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Cendikiawan, H., Radiology Departement, Eka Hospital Cibubur, West Java, Indonesia; Zaron, F., Radiology Departement, Eka Hospital Cibubur, West Java, Indonesia; Aryanti, I., Radiology Departement, Eka Hospital Cibubur, West Java, Indonesia; Irbah, S.N., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Hidayat, M., Faculty of Medicine, University of Mataram, Mataram, West Nusa Tenggara, Indonesia |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that causes coronavirus diseases 2019 (COVID-19). The SARS-CoV-2 is very contagious and nobody is known to be immune to it. The post-infected lung would leave a scar known as fibrosis, a scar tissue. A study from Wuhan, China suggested the development of fibrosis, though it was too early to label these lung changes as irreversible fibrosis in a time range of 3 weeks. The occurrence of fibrosis indicates a chronic infection which greatly contributes to the hallmark symptom of COVID-19 induced ARDS such as shortness of breath and chest pain. However, many of those studies have not yet explained the condition of the patient's lung after total recovery from the COVID-19. This report demonstrates the clinical symptoms, chest CT scan, spirometry, and blood gas analysis of patient after total recovery from the COVID-19 with appearance lung fibrosis. Copyright © 2021 Susanto et al. |
COVID-19; Lung fibrosis; Recovery |
ascorbic acid plus vitamin B complex; azithromycin; beta 2 adrenergic receptor stimulating agent; chloroquine; corticosteroid; hemoglobin; levofloxacin; meropenem; oseltamivir; adult; adult respiratory distress syndrome; Article; blood gas analysis; breathing rate; case report; cell count; clinical article; computer assisted tomography; coronavirus disease 2019; coughing; dyspnea; fever; forced expiratory volume; forced vital capacity; ground glass opacity; headache; hospitalization; human; lung examination; lung fibrosis; male; middle aged; nose smear; oropharyngeal swab; oxygen saturation; oxygen therapy; physical examination; pneumonia; quality of life; real time polymerase chain reaction; rhinorrhea; Severe acute respiratory syndrome coronavirus 2; spirometry; thorax pain; thorax radio |
Journal of Infection in Developing Countries |
20366590 |
|
33839710 |
Article |
Q3 |
322 |
14136 |
|
|